Zenith Drugs Bags Double Victory: Wins Tenders Valued at ₹83.3 Million

Zenith Drugs Limited has disclosed winning two major tenders, enhancing its order book by ₹83.3 million. This is further evidence of the company's increasing profile in the pharma supply chain.

 

Major points:

 

These success stories are preceded by Zenith's latest tender win in providing Clobetasol Propionate Cream and Ketoconazole with Zinc Pyrithione, worth about ₹200 million, to the Ministry of Defence.

 

The company's repeated tender victories are a testament to its robust market position and capability to fulfill strict quality requirements. With a product portfolio that is diversified in terms of ORS Powder, Liquid Orals, Ointments, and Capsules, Zenith Drugs stands well to leverage expanding demand in the pharma industry.

 

Sources: NSE filings, Zenith Drugs Limited announcements, March 17, 2025